Ginseng extract active ingredient can assist cancer treatment

American researchers reported on August 15th that animal studies have shown that ginseng extract active ingredients, ginsenoside triol, and similar compounds help to alleviate the side effects of certain cancer treatments.

Researchers at the Sloan-Kettering Cancer Institute in New York synthesized a compound similar to panaxyltriol, and then performed experiments on experimental mice with breast or colon cancer to test the compound to counteract the side effects of chemotherapy or radiotherapy. Ability. The results showed that injecting this compound into rats before receiving radiation therapy can reduce weight loss and blood cell damage caused by radiotherapy.

The researchers believe that ginsenoside triol and similar compounds can reduce the peripheral nerve damage caused by the anticancer drug paclitaxel and nausea-induced weight loss, and can reduce the damage of the anticancer drug 5-fluorouracil on red blood cells and white blood cells, thereby reducing drug users. The risk of infection and anaemia.

The research results were published on the same day in the new issue of the "Journal of the National Academy of Sciences." The researchers stated that ginsenoside triol and similar compounds can be a clinical option for the treatment of cancer. However, the chemical structure of ginsenic triol-like compounds needs to be optimized before clinical testing.